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Abstract. 
 
Expression of the 
 
Drosophila
 
 cell adhesion 
molecule neuroglian in S2 cells leads to cell aggregation 
and the intracellular recruitment of ankyrin to cell con-
tact sites. We localized the region of neuroglian that in-
teracts with ankyrin and investigated the mechanism 
that limits this interaction to cell contact sites. Yeast 
two-hybrid analysis and expression of neuroglian dele-
tion constructs in S2 cells identified a conserved 36-
amino acid sequence that is required for ankyrin bind-
ing. Mutation of a conserved tyrosine residue within 
this region reduced ankyrin binding and extracellular 
adhesion. However, residual recruitment of ankyrin by 
this mutant neuroglian molecule was still limited to cell 
contacts, indicating that the lack of ankyrin binding at 
noncontact sites is not caused by tyrosine phosphoryla-
tion. A chimeric molecule, in which the extracellular 
domain of neuroglian was replaced with the corre-
sponding domain from the adhesion molecule fasciclin 
II, also selectively recruited ankyrin to cell contacts. 
Thus, outside-in signaling by neuroglian in S2 cells de-
pends on extracellular adhesion, but does not depend 
on any unique property of its extracellular domain. We 
propose that the recruitment of ankyrin to cell contact 
sites depends on a physical rearrangement of neuro-
glian in response to cell adhesion, and that ankyrin 
binding plays a reciprocal role in stabilizing the adhe-
sive interaction.
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Drosophila
 
M
 
embers
 
 of the L1 family of cell adhesion mole-
cules (CAMs)
 
1
 
 have emerged as important mol-
ecules during embryonic nervous system devel-
opment and during regeneration after nerve injury
(Hortsch, 1996). They are involved in processes such as
myelination, long-term potentiation, neuronal migration,
axonal guidance and fasciculation, and synaptogenesis. L1
family members are also thought to transduce neurite
growth-promoting signals by activation of neuronal FGF
receptors (Walsh and Doherty, 1997).
There is compelling evidence linking mutations in hu-
man L1-CAM to neurodevelopmental phenotypes. These
phenotypes include hydrocephalus, motor neuron defects,
agenesis of the corpus callosum and the corticospinal tract,
and others (Wong et al., 1995
 
b
 
; Dahme et al., 1997). Muta-
tions in the 
 
Drosophila
 
 L1 homologue, neuroglian, result
in embryonic lethality and defects in neuronal morphology
and axonal pathfinding (Bieber et al., 1989; Hall and Bie-
ber, 1997). Which of L1’s many molecular functions are af-
fected by these mutations and are therefore responsible
for the observed phenotypes is currently unknown.
L1 family members with their conserved pattern of ex-
tracellular immunoglobulin (Ig) and fibronectin type III
protein domains share a number of molecular functions,
such as homo- and heterophilic adhesion (Hortsch, 1996).
The cytoplasmic domain binds directly to ankyrin which,
in turn, interacts with the spectrin cytoskeleton (Davis et al.,
1993; Davis and Bennett, 1994; Dubreuil et al., 1996;
Hortsch et al., 1998). Expression of the 
 
Drosophila
 
 L1 ho-
mologue, neuroglian, in 
 
Drosophila
 
 S2 tissue culture cells
results in a selective recruitment of ankyrin and spectrin to
sites of cell contacts (Dubreuil et al., 1996). Ankyrin re-
cruitment is strictly limited to cell contacts, even though
neuroglian is abundantly expressed over the entire cell
surface.
 
 
 
Thus, neuroglian can function as a signaling mole-
cule that transmits the positional value of cell adhesion to
the cytoplasmic assembly of ankyrin and spectrin. This
outside-in signaling function appears to be conserved
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among L1 family members, since expression of human L1
in S2 cells also results in the assembly of ankyrin at cell
contact sites (Hortsch et al., 1998). The adhesion-induced
rearrangement of ankyrin and spectrin can be conveyed to
other membrane proteins that interact with ankyrin and
spectrin and might thereby provide a mechanism for the
assembly of unique plasma membrane subdomains. For
example, the NaK-ATPase, which is known to interact
with ankyrin in vertebrates (Nelson and Veshnock, 1987),
was found to accumulate along with spectrin and ankyrin
at sites of neuroglian-mediated adhesion in S2 cells (Du-
breuil et al., 1997). Thus, L1-mediated adhesion events re-
sult in a reorganization and compartmentalization of the
plasma membrane, which may constitute an important bi-
ological function of L1 family members.
Recent studies of the L1 family member rat neurofascin
have begun to elucidate the structural requirements of the
L1 family–ankyrin interaction. Deletion of a five-amino
acid sequence from the conserved distal region of the neu-
rofascin cytoplasmic domain abolished ankyrin binding
(Garver et al., 1997), indicating that this sequence contrib-
utes to the ankyrin-binding site. Two tyrosine residues in
this distal region (corresponding to Y1217 and Y1234 in
the 
 
Drosophila 
 
neuroglian protein sequence) are con-
served in all but two members of the L1 family. In vitro
studies of neurofascin revealed that phosphorylation of
one of these tyrosines (Y1234 in neuroglian) can inhibit
the binding of ankyrin to neurofascin (Garver et al., 1997).
Furthermore, inhibition of the ankyrin–neurofascin inter-
action, either by deleting or phosphorylating the critical
tyrosine residue, had an inhibitory effect on neurofascin-
mediated cell adhesion (Tuvia et al., 1997). Together,
these observations suggest an elegant mechanism to ex-
plain the inside-out regulation of the extracellular adhe-
sion of an L1 family member by the intracellular phos-
phorylation of its cytoplasmic domain.
Here we investigate the mechanisms governing outside-
in signaling by neuroglian. We take advantage of the
unique features of S2 cells to study not only adhesion, but
also the redistribution of the spectrin cytoskeleton in re-
sponse to neuroglian expression (Dubreuil et al., 1996).
We used yeast two-hybrid analysis and expression of dele-
tion constructs in S2 cells to map the region of neuroglian
that is necessary and sufficient for binding to ankyrin. Sim-
ilarly, we investigated the effects of cytoplasmic domain
tyrosine mutations on the ability of neuroglian to interact
with ankyrin in yeast and to recruit ankyrin to cell contacts
in S2 cells. Finally, we tested the possibility that neuro-
glian outside-in signaling depends on unique features of
the neuroglian extracellular domain by expressing a fasci-
clin II-neuroglian chimera in S2 cells. The results of these
studies expand the repertoire of molecular mechanisms
that are relevant to our understanding of L1 family func-
tion and the relationship between specific L1 defects and
their complex phenotypes.
 
Materials and Methods
 
Materials and Antibodies
 
The 1B7 and 3F4 mAbs against 
 
Drosophila 
 
neuroglian, a rat antiserum
specific for the neuroglian
 
167
 
 protein (Bieber et al., 1989; Hortsch et al.,
1995) and affinity-purified rabbit anti-
 
Drosophila
 
 ankyrin (Dubreuil and
Yu, 1994) have been described earlier. The rat antiserum and the mouse
1D4 mAb against
 
 Drosophila
 
 fasciclin II, as well as the cDNA for the
PEST sequence-containing, transmembrane protein form of 
 
Drosophila
 
fasciclin II were kind gifts of C. Goodman (University of California, Ber-
keley, CA). Rabbit anti-phosphotyrosine antibody (She et al., 1997) was a
gift of C. Palfrey (University of Chicago, Chicago, IL). Schneider’s me-
dium, penicillin/streptomycin solution, and fetal calf serum were from Life
Technologies, Inc. (Gaithersburg, MD).
 
Construction of cDNAs for S2 Cell 
Transfection Experiments
 
Cytoplasmic domain deletions were produced by PCR with neuroglian
 
167
 
cDNA as template and PCR products were initially subcloned in the pAS-
CYH2 vector. 5
 
9 
 
PCR primers used in these PCRs contained a NcoI site
(maintaining an open reading frame with the GAL4 DNA-binding do-
main), followed by a NsiI site; 3
 
9 
 
PCR primers contained a SalI site. The
numbers in the designation of individual deletion constructs refer to the
85 amino acid residues of the cytoplasmic domain of the neuroglian
 
167
 
 pro-
tein form. Carboxy-terminal deletions were created by the introduction of
in-frame stop codons along the neuroglian sequence using the 3
 
9 
 
PCR
primer; deletions in the amino-terminal region of the neuroglian cDNA
by using several 5
 
9 
 
PCR primers with homology to different regions of the
neuroglian cDNA. The fidelity of the PCR amplification reactions was
verified by DNA sequence analysis (Sanger et al., 1977).
Constructs incorporating the cytoplasmic deletions into the complete
neuroglian open reading frame were derived from the first set of verified
pAS1-CYH2 plasmids. NsiI/SalI cDNA fragments were isolated from the
pAS1-CYH2 DNAs and introduced into the context of the entire neuro-
glian open reading frame by subcloning into pRmHa3:nrg
 
NsiI
 
 vector DNA.
This vector was created by using PCR to introduce a silent C to A point
mutation at position 3,480 of the neuroglian sequence at the end of the re-
gion encoding the transmembrane segment, thereby creating a unique
NsiI site.
Neuroglian cDNAs with point mutations converting cytoplasmic ty-
rosine residues into phenylalanine residues were created using the follow-
ing strategy. The unique BamHI site at position 3,710 of the neuroglian
 
167
 
cDNA sequence was used in a two-step PCR process to create initially sin-
gle and subsequently double point mutations. This was accomplished by
converting the flanking codons encoding tyrosine 1,217 and tyrosine 1,234
into phenylalanine-encoding codons. PCR primers including the BamHI
site and one of the Y to F mutated codons (TAT/C to TTT/C) were used
in separate PCR reactions and subsequently subcloned into BamHI and
either NcoI- or SalI-digested pAS1-CYH2:nrg
 
wt
 
 (construct no. 1, wt) vec-
tor DNA. The incorporation of only the desired point mutation(s) was
verified by DNA sequence analysis. As described above for the deletion
mutations, all three cDNA fragments encoding Y to F mutated,
neuroglian
 
167
 
 cytoplasmic domains were subsequently subcloned into the
pRmHa3:nrg
 
NsiI
 
 vector for transfection of S2 cells.
A chimeric cDNA was constructed by the in-frame fusion of DNA
fragments encoding the extracellular domain of 
 
Drosophila 
 
fasciclin II
and the transmembrane segment plus the cytoplasmic domain of 
 
Dro-
sophila 
 
neuroglian
 
167
 
. A 0.45-kb KpnI/SalI PCR product encoding the
neuroglian transmembrane segment and the cytoplasmic domain was de-
rived from a 
 
Drosophila 
 
neuroglian
 
167
 
 
 
cDNA and subcloned into
pRmHa3 vector DNA. Besides the KpnI cloning site, the 5
 
9 
 
PCR primer
also introduced an AatII site which was in-frame with the AatII site at po-
sition 2,581 in the fasciclin II cDNA. This interim construct was cut with
KpnI and AatII and then ligated to a 2.6-kb fasciclin II cDNA fragment,
resulting in the final pRmHa3–fasII
 
EC
 
–nrg
 
TM
 
1
 
CP
 
 construct. The entire
open reading frame of the transmembrane, PEST sequence-containing
fasciclin II cDNA, was subcloned into the pRmHa3 vector yielding the
pRmHa3–fasII
 
PEST
 
 construct.
 
Generation and Maintenance of S2 Cell Lines
 
All 
 
Drosophila
 
 S2 cell lines were transfected using Lipofectin
 
® 
 
(Life Tech-
nologies, Inc.) and clonal lines were maintained as previously described
(Bieber, 1994). After induction with 0.7 mM of CuSO
 
4
 
, subclones were an-
alyzed by Western blotting for high level expression of recombinant pro-
teins and subclones expressing comparable quantities of neuroglian were
selected for further experiments. 
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Cell Aggregation Experiments
 
The ability of mutated neuroglian to induce homophilic cell aggregation
of transfected S2 cells was tested as described earlier (Hortsch et al.,
1995). Cell lines were adjusted to a concentration of 10
 
6
 
 cells/ml and neu-
roglian synthesis was induced by the addition of 0.7 mM of CuSO
 
4
 
. Dupli-
cate cultures (10
 
6
 
 cells in 1 ml) were grown in six-well tissue culture plates
and induced at 25
 
8
 
C for 15 h. Cells were transferred to sterile 50-ml centri-
fuge tubes and further incubated on a shaking platform (model 62; New
Brunswick Sci. Co., Edison, NJ) at 200 rpm. For a quantitative analysis,
the number of nonaggregated cells was counted in a hemocytometer
(Bright-Line
 
®
 
; Reichert, Buffalo, NY). Since cell clusters of up to five
cells were occasionally observed in untransfected S2 cells, only aggregates
containing more than five cells were considered to be aggregated. Eight
fields, each representing 0.01 
 
m
 
l of cell suspension, were counted per cul-
ture. Based on the starting number of cells, the results are presented as
percent aggregated cells of total cells.
 
SDS-PAGE and Western Blot Analysis
 
For Western blots, transfected S2 cells were pelleted and solubilized in
SDS-containing buffer. Total cell proteins were separated by PAGE,
transferred onto nitrocellulose filters, and then probed with specific anti-
bodies as described (Hortsch et al., 1985; Dubreuil et al., 1987). Proteins
were separated on either 7.5/0.2% or 8.0/0.08% acrylamide:bisacrylamide
gels.
 
Yeast Two-Hybrid Analysis
 
The yeast two-hybrid system was used as described by Durfee et al.
(1993). The pACTII–ankyrin construct has been characterized previously
(Dubreuil et al., 1996). The pACTII-control plasmid was kindly provided
by J. Clemens (University of Michigan, Ann Arbor, MI). Yeast selection
plates and media were made and yeast transformations were performed
using established protocols (Ausubel et al., 1988). Staining for 
 
b
 
-galactosi-
dase expression in yeast cell colonies was assayed using the substrate
5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
d
 
-galactopyranoside as described (Bartel et
al., 1993). Quantitative determinations of 
 
b
 
-galactosidase expression were
done on 4-ml liquid yeast cultures using 
 
O
 
-nitrophenyl-
 
b
 
-
 
d
 
-galactoside as
substrate (Ausubel et al., 1988).
 
Immunofluorescence Staining and Microscopy
 
Immunofluorescence analysis of 
 
Drosophila
 
 ankyrin distribution in S2 cell
aggregates was performed as described previously (Dubreuil et al., 1996).
Briefly, cells were attached to alcian blue–coated microscope slides, fixed
in 4% paraformaldehyde, permeabilized in 0.1% Triton X-100, and then
reacted with antibodies and washed in pH 7.5 Tris-buffered saline con-
taining 5% newborn calf serum.
 
Results
 
A Conserved Distal Region of the Neuroglian 
Cytoplasmic Domain Binds Ankyrin
 
To determine the cytoplasmic neuroglian subdomains that
are involved in ankyrin binding, we engineered a series of
neuroglian deletion constructs to test their ability to inter-
act with 
 
Drosophila
 
 ankyrin (Fig. 1). Deletion breakpoints
were selected to isolate several protein segments that are
broadly conserved among members of the L1 gene family.
It has previously been shown that these conserved regions
form functionally and structurally important L1 subdo-
mains, such as the ankyrin-binding site (Davis and Ben-
nett, 1994; Garver et al., 1997; Tuvia et al., 1997).
Since the interaction between the full-size neuroglian
cytoplasmic domain and 
 
Drosophila 
 
ankyrin can be
readily detected using the yeast two-hybrid assay system
(Dubreuil et al., 1996; Fig. 2), these neuroglian deletion
constructs were initially tested for their ability to interact
with a 
 
Drosophila
 
 ankyrin fusion protein in yeast cells. All
constructs containing deletions within the amino-terminal
Figure 1. cDNA constructs introducing various deletions and point mutations into the cytoplasmic domain of Drosophila neuroglian.
Truncations at the amino- and carboxyl-terminal end of the neuroglian167 cytoplasmic domain, an internal deletion, and tyrosine to phe-
nylalanine point mutations were generated by PCR as described in the Materials and Methods section. Lines represent the wild-type or
mutated neuroglian cytoplasmic domains, starting at the first basic amino acid residue after the membrane-spanning segment and end-
ing at the carboxy-terminus of the protein. The results of the yeast two-hybrid interaction between Drosophila ankyrin and the neuro-
glian cytoplasmic deletion proteins, as well as the ability of these deleted neuroglian molecules to induce S2 cell aggregation and to re-
cruit ankyrin to S2 cell contacts are summarized on the righ.Wild-type activity levels are indicated with 11. At the bottom of the figure,
cytoplasmic amino acid residues which are conserved in more than 90% of all known L1 family members are shown. 
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48-amino acid residues of the cytoplasmic domain inter-
acted with ankyrin at or near wild-type levels in yeast cells
(Fig. 2). In all constructs missing the 19 most carboxy-ter-
minal amino acid residues, the neuroglian–ankyrin inter-
action was significantly reduced, although not abolished.
With the exception of construct no. 5, all constructs includ-
ing residues 49–65 of the neuroglian cytoplasmic protein
domain exhibited strong binding to the ankyrin fusion pro-
tein. Yeast colonies transfected with construct no. 5, which
lacks the carboxy-terminal 19-amino acid residues of the
neuroglian cytoplasmic domain, developed a weak signal
only after prolonged incubation. In contrast, after the
same length of incubation no positive signal was ever de-
tected in yeast colonies harboring control pAS-CYH2
plasmids or neuroglian deletion constructs nos. 4, 6, 7, or 8.
The smallest region which mediated ankyrin binding at a
low level consists of a well conserved 17-amino acid seg-
ment (Fig. 1; present in construct no. 3 and absent in con-
struct no. 4). High efficiency binding between the neuro-
glian and the ankyrin fusion proteins, however, was only
observed when the adjacent carboxy-terminal 19-amino
acid residues were also present. These results indicate that
Figure 2. A qualitative and quantitative yeast two-hybrid analysis maps the minimal
ankyrin binding site to a 17-amino acid segment within the Drosophila neuroglian cytoplas-
mic domain with the next 19 carboxy-terminal amino acid residues being required for
high efficiency binding. (A) Qualitative yeast two-hybrid analysis of the interaction be-
tween neuroglian cytoplasmic domain fragments and Drosophila ankyrin. Blue colonies
result from the induction of b-galactosidase activity and indicate an interaction between
the two GAL4 fusion proteins. Top row, yeast colonies containing a pACTII–Drosophila
ankyrin construct (expressing a GAL4 activation domain–Drosophila ankyrin fusion pro-
tein) as well as a pAS1–CYH2 construct (expressing a fusion protein consisting of the
GAL4 DNA-binding domain and a wild-type or deleted neuroglian cytoplasmic domain);
bottom row, yeast colonies containing the same pAS1–CYH2 constructs and a pACTII vec-
tor control that did not result in an activation of b-galactosidase expression. (B) Quantita-
tive analysis of the effects of neuroglian cytoplasmic deletions on the yeast two-hybrid
neuroglian–ankyrin interaction. Data bars represent the mean 6 SD from three different
yeast colonies performed in triplicate determinations.
Figure 3. Quantitative evaluation of S2
cell aggregation induced by the expres-
sion of mutated neuroglian. For a
quantification of S2 cell aggregation,
duplicate cultures were prepared, in-
duced for 15 h at low cell density, and
then processed as described in the Ma-
terials and Methods section. Cells that
had not aggregated were counted
(minimal aggregate size .5 cells) and
the number of aggregated cells was cal-
culated as the difference to the total
number of cells. Shown is the percent-
age of total cells which had aggregated
after 2 h of shaking. Data bars repre-
sent the mean 6 SD from two indepen-
dent experiments. 
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the conserved FIGQY motif, which was previously shown
to be important for ankyrin binding (Davis and Bennett,
1994; Garver et al., 1997), is necessary but not sufficient
for high efficiency ankyrin binding. A low-level interaction
with ankyrin was still observed for two constructs (nos. 5
and 9) missing this motif.
The same set of cytoplasmic domain deletions was
spliced to the remainder of the full-length neuroglian cod-
ing sequence for expression studies in 
 
Drosophila
 
 S2 cells.
These recombinant neuroglian cDNA constructs yielded
polypeptides with the expected apparent molecular weights
in Western blots probed with anti-neuroglian antibodies
(data not shown) and they induced robust S2 cell aggrega-
tion (Fig. 3 
 
A
 
). A double-label immunofluorescence analy-
sis of the neuroglian and ankyrin distribution in S2 cells in-
dicated that wild-type neuroglian was abundant over the
entire cell surface, yet ankyrin was exclusively recruited to
sites of cell–cell contact (Dubreuil et al., 1996; Fig. 4 
 
A
 
).
Expression of the 
 
D
 
18N neuroglian deletion protein
(construct no. 2, lacking the 18 amino-terminal residues of
the cytoplasmic domain) in S2 cells resulted in the same
pattern of ankyrin and neuroglian staining which was ob-
 
served with wild-type neuroglian (Fig. 4 
 
B
 
). However,
none of the other deletion constructs tested (e.g., 
 
D
 
18N
 
;
 
D
 
19C 
 
shown in Fig. 4 
 
C
 
) produced any detectable staining
of ankyrin at cell contacts or other regions of the cell sur-
face, even though the mutant neuroglian proteins were
abundantly expressed at the plasma membrane. Thus, the
ankyrin recruitment assay in S2 cells revealed a more com-
plex requirement of the neuroglian cytoplasmic domain in
ankyrin binding than was expected based on the results of
the yeast two-hybrid assay.
 
Functional Analysis of Conserved Tyrosine Residues in 
the Cytoplasmic Domain of Neuroglian
 
A conserved cytoplasmic tyrosine residue in rat neurofas-
cin, corresponding to Y1234 in neuroglian, was previously
Figure 4. A conserved membrane-proximal segment of the neu-
roglian cytoplasmic domain is dispensable for recruitment of
ankyrin to cell contacts in S2 cells. S2 cells expressing wild-type
or cytoplasmic deletion Drosophila neuroglian were allowed to
aggregate and were double stained with a polyclonal rabbit anti-
Drosophila ankyrin (left column) and a mouse anti-Drosophila
neuroglian antibody (right column) followed by fluorescently-
labeled secondary antibodies. Cells were permeabilized before
staining by treatment with 0.1% Triton X-100. Drosophila
ankyrin was recruited to cell contact sites (arrows) in cell aggre-
gates expressing either wild-type neuroglian (A) or neuroglian in
which the first 18 amino acid residues of the cytoplasmic domain
had been deleted (construct no. 2 shown in row B). All other de-
letions in the cytoplasmic neuroglian domain abolished ankyrin
recruitment (as shown for construct no. 9 in panels C). Bar, 10 mm.
Figure 5. Qualitative and quantitative yeast two-hybrid analysis
of the interaction between Drosophila ankyrin and neuroglian167
cytoplasmic domains with tyrosine to phenylalanine amino acid
substitutions. (A) Qualitative yeast two-hybrid analysis of the in-
teraction between Y to F neuroglian cytoplasmic domain muta-
tions and Drosophila ankyrin. Blue colonies result from the in-
duction of b-galactosidase activity and indicate an interaction
between the two GAL4 fusion proteins. Top row, yeast colonies
containing a pACTII–Drosophila ankyrin construct (expressing a
GAL4 activation domain–Drosophila ankyrin fusion protein) as
well as a pAS1-CYH2 construct (expressing a fusion protein con-
sisting of the GAL4 DNA-binding domain and a neuroglian cyto-
plasmic domain, which was either wild-type or contained one or
two point mutations resulting in Y to F amino acid substitutions);
bottom row, yeast colonies containing the same pAS1–CYH2
constructs and a pACTII vector control. (B) Quantitative evalua-
tion of b-galactosidase expression in the yeast cells shown in A.
Data bars represent the mean 6 SD from two different experi-
ments performed in triplicate determinations.The Journal of Cell Biology, Volume 142, 1998 256
shown to have a possible regulatory role, since phosphory-
lation of this residue inhibited the binding of ankyrin to
neurofascin in vitro (Garver et al., 1997). Here the effects
of tyrosine to phenylalanine mutations at two positions of
the Drosophila neuroglian cytoplasmic domain on ankyrin
binding were evaluated using a yeast two-hybrid assay.
The residues Y1217 and Y1234 in neuroglian correspond
to the tyrosine residues in rat neurofascin which were mu-
tated and analyzed by Garver et al. (1997). Replacement
of Y1217 with a phenylalanine had no detectable effect on
ankyrin binding (Fig. 5). However, the Y1234F mutation
had a significant effect, reducing ankyrin binding by
z50%. The double mutant Y1217F/Y1234F form reduced
ankyrin binding to a similar extent. Thus, the conserved
Y1234 contributes to the interaction between ankyrin and
neuroglian. However, in contrast to rat neurofascin (Tuvia
et al., 1997), substitution of the tyrosine residue with phe-
nylalanine in neuroglian greatly reduced its ability to bind
ankyrin.
The same tyrosine mutations (Y1217F and Y1234F)
were engineered into the complete neuroglian coding se-
quence for analysis of ankyrin-binding activity in S2 cells.
Aggregates expressing wild-type neuroglian were typically
large and cells often exhibited significant neuroglian stain-
ing over all regions of the plasma membrane (Fig. 6 A, ar-
row). In contrast, the most conspicuous ankyrin staining
was observed at cell–cell contacts (Fig. 6 A, right). Addi-
tional ankyrin staining was visible as a diffuse pattern
throughout the cytoplasm and, in many cases, as a punc-
tate pattern in the peripheral cytoplasm. This fainter pat-
tern of ankyrin staining is probably not associated with the
plasma membrane since it failed to colocalize with plasma
membrane markers such as neuroglian, and it was also vis-
ible in the absence of neuroglian expression (Dubreuil
et al., 1996). The same patterns of neuroglian and ankyrin
staining were observed in cultures expressing the Y1217F
mutant form of neuroglian (Fig. 6 B), although the effi-
ciency of ankyrin recruitment was slightly lower than with
wild-type neuroglian (Fig. 7). There was a dramatic drop
in the efficiency of ankyrin recruitment in cells expressing
the Y1234F neuroglian mutation or the double mutant
(Fig. 6, C–F, arrowheads). Most contact sites in which neu-
roglian was prominently stained showed little or no re-
cruitment of ankyrin in cells expressing the Y1234F muta-
tion (e.g., Fig. 6 F). Nevertheless, ankyrin was consistently
detected at sites of cell–cell contact in a fraction of cell ag-
gregates expressing these mutations (Fig. 6, C–F and Fig. 7).
Although there was a significant effect of the Y1234F
mutation on the efficiency of ankyrin recruitment, there
was no apparent effect on the selectivity of recruitment.
As with wild type, the only significant colocalization of
ankyrin with Y1234F neuroglian occurred at sites of cell
contact (Fig. 6, C–E), even though neuroglian was often
abundant at noncontact regions of the plasma membrane
(e.g., Fig. 6 D, arrow). It should be noted that although the
panels shown in the figure were chosen to demonstrate the
selectivity of ankyrin recruitment, most of the mutant cell
clusters analyzed in the experiment did not exhibit detect-
able ankyrin staining at cell contacts (Fig. 7). Ankyrin also
failed to colocalize with neuroglian in single cells that had
not yet joined an aggregate (Fig. 6 G). These results are
consistent with the previous observation that ankyrin colo-
calizes with neuroglian only at sites of cell contact, and not
with neuroglian found at noncontact regions of the plasma
membrane (Dubreuil et al., 1996). Since cytoplasmic ty-
rosine mutations did not lead to colocalization of ankyrin
Figure 6. A cytoplasmic
tyrosine residue is required
for efficient recruitment of
ankyrin to cell contacts in neu-
roglian-expressing S2 cells. S2
cells were induced to express
wild-type neuroglian (A),
nrgY1217F ( B ), nrgY1234F ( C
and  D), or double mutant
neuroglian (E–G) for 24 h
before processing for anti-
body labeling of neuroglian
(left panels) and ankyrin
(right panels) as in Fig. 4. Ar-
rows, abundance of neuro-
glian at noncontact regions
of the plasma membrane; ar-
rowheads, cell contact sites in
mutant cells with little or no
recruitment of ankyrin. Bar,
10 mM.Hortsch et al. Requirements for Neuroglian Signaling 257
with neuroglian at noncontact regions of the plasma mem-
brane, a mechanism other than the phosphorylation of
these residues must be responsible for the observed selec-
tivity of ankyrin recruitment.
Drosophila Neuroglian Is Not Detectably 
Phosphorylated at Tyrosine Residues in S2 Cells
Further evidence that tyrosine phosphorylation is not re-
sponsible for neuroglian regulation in S2 cells was ob-
tained by staining Western blots of neuroglian-expressing
S2 cell lysates with a phosphotyrosine-specific antibody
(Fig. 8). After induction, neuroglian was readily detected
with a neuroglian-specific antibody (Fig. 8, lane 2, left col-
umn), but not with the anti-phosphotyrosine antibody
(Fig. 8, lane 2, right column). Faint bands in the region of
neuroglian were also detected by the anti-phosphotyrosine
antibody in uninduced cells (Fig. 8, lane 1, right column)
where neuroglian was undetectable (Fig. 8, lane 1, left col-
umn). PC12 cells treated with nerve growth factor were
used as a positive control. Tyrosine-phosphorylated mito-
gen-activated protein (MAP) kinase was readily detected
in growth factor-induced PC12 cells (Fig. 8, lane 4, **) but
not in control untreated cells (Fig. 8, lane 3) (Boulton et
al., 1991).
Neuroglian-mediated Adhesion Is Subject to
Inside-Out Regulation
The effect of cytoplasmic mutations on neuroglian-medi-
ated cell adhesion was analyzed in qualitative and quanti-
tative S2 cell aggregation assays. It was previously shown
that a glycosyl phosphatidylinositol-linked form of neuro-
glian lacking the entire cytoplasmic domain nevertheless
exhibited robust cell adhesion (Hortsch et al., 1995). All of
the neuroglian cytoplasmic domain deletion mutants ana-
lyzed here also exhibited strong cell aggregation compara-
ble to cells expressing wild-type neuroglian (refer to Fig. 3
A). In contrast, when analyzing the Y to F mutant neuro-
glian forms for their competence to recruit ankyrin in S2
cells, we observed that neuroglian molecules harboring a
Y1234F mutation consistently induced smaller cell aggre-
gates when compared with wild-type or Y1217F-mutant
forms (Fig. 9, A–E). Although a majority of cells express-
ing wild-type or Y1217F-mutant neuroglian had joined
large cell aggregates after 2 h of incubation, cell aggrega-
tion was significantly reduced in S2 cell cultures expressing
Y1234F-mutant neuroglian (Fig. 9 D). After prolonged in-
cubation times (4–24 h) the mutant neuroglian-expressing
cell lines did form somewhat larger aggregates, but never
reached wild-type levels (data not shown). This effect was
not due to a reduced level of neuroglian protein produced
by these cell lines, since Western blot analysis demon-
strated similar quantities of neuroglian in induced cultures
(Fig. 9 F).
Outside-In Signaling by a 
Fasciclin II–Neuroglian Chimera
The mechanism behind the adhesion-based neuroglian sig-
nal was further examined with a chimeric cDNA com-
posed of the extracellular domain of the Drosophila CAM
fasciclin II linked to the cytoplasmic and transmembrane
domains of neuroglian. Fasciclin II is also a member of the
Ig superfamily, but it is distantly related in sequence and
distinct from neuroglian in domain organization (Grennin-
gloh et al., 1991). If the neuroglian signal is simply a conse-
quence of cell adhesion, then the chimera should mimic
authentic neuroglian in its ability to induce the recruit-
ment of ankyrin to sites of cell contact. However, if the sig-
nal depends on allosteric communication between the ex-
tracellular and intracellular domains of neuroglian, then
the signal should be uncoupled in the chimeric molecule.
The fasciclin II cDNA used here encodes a 115-kD trans-
membrane protein with a 104-amino acid cytoplasmic do-
Figure 7. Quantification of ankyrin recruitment in S2 cells ex-
pressing neuroglian proteins mutated at cytoplasmic tyrosines.
Populations of transfected S2 cells expressing wild-type neuro-
glian (Nrg167) or the indicated tyrosine mutations of neuroglian
were double labeled with mouse anti-neuroglian and rabbit anti-
ankyrin antibodies as in Fig. 3. In each experiment, 100 S2 cell
clusters were identified by virtue of their neuroglian expression
and then scored for the presence or absence of detectable
ankyrin staining at cell contacts. Data bars represent the mean 6
SD from two independent experiments.
Figure 8. Neuroglian is not
phosphorylated on tyrosine
residues in S2 cells. Western
blots of total S2 cell proteins
from uninduced cells (lane 1)
or cells induced to express
neuroglian (lane 2) were
stained with mouse anti-neu-
roglian (lanes 1 and 2, left
columns) or rabbit anti-phos-
photyrosine antibodies (right
columns). Antibody binding
was detected with alkaline
phosphatase-conjugated sec-
ondary antibodies. Total pro-
teins from control PC12 cells
(lane 3) and nerve growth factor-stimulated PC12 cells (lane 4)
were also stained with anti-phosphotyrosine antibody. The posi-
tions of neuroglian (*), MAP kinase (**) and molecular weight
standards (left) are indicated.The Journal of Cell Biology, Volume 142, 1998 258
main that is unrelated to neuroglian (Fig. 10). Expression
of authentic fasciclin II in S2 cells caused extensive cell ag-
gregation (Fig. 11, A and B), but did not direct ankyrin re-
cruitment to cell contacts (Fig. 11 A). In contrast, expres-
sion of the fasciclin II-neuroglian chimera resulted in cell
aggregation and recruitment of ankyrin to sites of cell–cell
contact (Fig. 11, C and E). Ankyrin was not recruited to
nonadherent regions of the plasma membrane in cell ag-
gregates or to the plasma membrane in single cells ex-
pressing the chimaera (data not shown). The fasciclin II
staining pattern appeared concentrated at sites of cell–cell
contact in detergent-permeabilized cells (Fig. 11, B and
D). However, control experiments with nonpermeabilized
cells revealed that the chimaera was also abundant at non-
adherent regions of the plasma membrane (Fig. 11 D, in-
set). Thus, ankyrin recruitment coincided with sites of cell
adhesion and not with the total distribution of the chi-
meric molecule. These results indicate that cell adhesion is
a sufficient signal to activate recruitment of ankyrin by the
cytoplasmic domain of neuroglian.
Discussion
In addition to their primary roles in cell adhesion, adhe-
sion molecules from the integrin and cadherin families
transduce signals across the plasma membrane (Clark and
Brugge, 1995; Gumbiner, 1995). Here we show that neuro-
glian, a CAM from the Ig superfamily, also has the ability
to transduce signals in both directions across the plasma
membrane. First, we have investigated the structural re-
quirements for outside-in signaling which leads to selec-
tive binding of ankyrin to neuroglian at sites of cell con-
tact. Studies of a fasciclin II-neuroglian chimera revealed
that adhesion, rather than any unique property of neuro-
Figure 9. S2 cells expressing neuroglian with a cytoplasmic
Y1234F mutation exhibit a reduced level of cell aggregation. S2
cell lines that had been transfected with either wild-type (B) or
mutated neuroglian cDNA constructs (C, NrgY1217F; D, NrgY1234F;
and E, NrgnrgY1217/1234F) were induced for 15 h with Cu21 ions and
subsequently incubated at room temperature on a shaking plat-
form at 200 rpm for 4 h. (A) Control cells not expressing neuro-
glian. S2 cells cultures were processed in parallel for Western blot
analysis and probed with the neuroglian-specific 3F4 mAb (F).
The equivalent of 5 3 105 cells was loaded in each lane. Bar, 200 mm.
Figure 10. Western blots of fasciclin II, neuroglian, and fasciclin
IIEC-neuroglianTM1CP hybrid proteins expressed in S2 cells. S2
cells, which had been transfected with a fasciclin II (PEST form)
(lanes  1), a neuroglian167 (lanes 2), or a fasciclin IIEC-
neuroglianTM1CP (lanes 3) cDNA construct, were induced over-
night and processed for Western blot analysis. Blot A was incu-
bated with the neuroglian-specific mAb 3F4 which recognizes an
epitope on the neuroglian extracellular domain, blot B with a rat
polyclonal antiserum which was raised against the entire fasciclin
II protein, blot C with the mAb 1D4 which binds to a cytoplasmic
epitope of the fasciclin II (PEST) protein form, and blot D with a
polyclonal rat antiserum which was raised against a small peptide
representing the eight carboxy-terminal amino acid residues of
the neuroglian167 form.Hortsch et al. Requirements for Neuroglian Signaling 259
glian’s extracellular domain, activates ankyrin binding to
the intracellular domain. Phosphorylation of a conserved
cytoplasmic tyrosine residue, which was recently shown to
inhibit ankyrin binding to a vertebrate neuroglian homo-
logue, neurofascin (Garver et al., 1997; Tuvia et al., 1997),
did not regulate ankyrin binding to neuroglian in S2 cells.
Second, the extracellular adhesive activity of neuroglian
was found to be regulated by the state of the cytoplasmic
domain. Although the biological significance of this level
of regulation is not yet known, it provides a simple mecha-
nism for the spatial and temporal regulation of L1 family
members. These observations broaden our understanding
of how extracellular adhesion directs rearrangement of the
spectrin/ankyrin membrane skeleton within the cell and
how protein interactions inside the cell can regulate extra-
cellular adhesion.
Whereas the inside-out regulation of neuroglian’s adhe-
sive function is one finding of the present study, our ap-
proach has largely been directed toward the mechanism of
outside-in signaling. Drosophila S2 cells provide a unique
model system in which to study the recruitment of ankyrin
to the plasma membrane, since ankyrin is not ordinarily
associated with the plasma membrane of these cells. We
previously demonstrated that both Drosophila neuroglian
(Dubreuil et al., 1996) and human L1-CAM (Vallejo et al.,
1997; Hortsch et al., 1998) induce the selective recruitment
of ankyrin to sites of cell contact, even though the adhe-
sion molecules themselves are broadly expressed over the
entire cell surface. Once neuroglian has interacted with
ankyrin at cell–cell contact sites, it becomes resistant to ex-
traction by nonionic detergents (Dubreuil et al., 1996).
This change in the solubility of neuroglian precludes an
analysis of the neuroglian–ankryin interaction by immuno-
precipitation techniques and, when using immunofluores-
cence microscopy, results in an underrepresentation of
neuroglian staining at noncontact areas of the S2 plasma
membrane.
It was previously shown that the FIGQY sequence,
which is highly conserved throughout the L1 family, pro-
vides an essential part of the ankyrin-binding domain in
rat neurofascin (Davis and Bennett, 1994; Garver et al.,
1997). Through a combination of yeast two-hybrid analysis
and expression of mutated neuroglian molecules in S2
cells, we have mapped a larger, 36-amino acid segment in
the neuroglian cytoplasmic domain, which includes this
conserved motif, that is both necessary and sufficient to al-
low the interaction between neuroglian and ankyrin.
The demonstration that ankyrin binding to rat neurofas-
cin can be regulated by phosphorylation of the tyrosine
residue in the FIGQY motif (Garver et al., 1997; Tuvia et al.,
1997) suggested a possible mechanism to explain outside-
in regulation of neuroglian. Phosphorylation of this con-
served tyrosine in the cytoplasmic domain of neurofascin
caused an z40% reduction in ankyrin binding and a com-
parable decrease in cell aggregation. Based on these prop-
erties of neurofascin, we hypothesized that the association
of ankyrin with neuroglian in S2 cells could also be regu-
lated by tyrosine phosphorylation, assuming that the phos-
phorylation of the tyrosine residue in the FIGQY motif is
regulated by cell adhesion.
If neuroglian were phosphorylated on tyrosine residues
in S2 cells, and phosphorylation was responsible for the
lack of ankyrin binding to neuroglian at noncontact sites
of aggregated S2 cells, then the mutation of tyrosine resi-
due 1234 in Drosophila neuroglian would be expected to
cause ankyrin binding indiscriminately at all regions of the
plasma membrane. Although the neuroglian Y1234F mu-
tation greatly reduced the extent of ankyrin binding to
neuroglian, it did not affect the selective association of
ankyrin at sites of cell–cell contact or the lack of ankyrin at
noncontact regions of the plasma membrane. Thus, an-
other mechanism must be responsible for the outside-in
regulation of ankyrin recruitment in S2 cells. We therefore
suggest that the previously observed effects of tyrosine
phosphorylation on rat neurofascin constitutes a mecha-
nism of regulation that might be specific for the neurofas-
cin subfamily. Alternatively, tyrosine phosphorylation
may operate in regulating ankyrin binding to L1 molecules
in some cell types, such as the B104 neuroblastoma cell
line, but not in other cells. S2 cells may simply lack a ty-
rosine kinase of the appropriate specificity for the FIGOY
motif to produce an effect on ankyrin binding. It is impor-
Figure 11. Selective recruitment of ankyrin to cell contacts in S2
cells expressing a chimeric neuroglian molecule. S2 cells were in-
duced to express the adhesion molecule fasciclin II (A and B) or
a chimeric molecule (fasciclin IIEC-neuroglianTM1CP) in which the
extracellular neuroglian domain was replaced with the corre-
sponding domain from fasciclin II (C–F). Cells were induced for
48 h and then processed for immunofluorescent staining with an-
tibodies against ankyrin (A, C, and E) and against the extracellu-
lar domain of either fasciclin II (B and D) or neuroglian (F). Con-
trol experiments (D, inset) revealed that fasciclin II was
abundantly detected at all regions of the plasma membrane when
the detergent permeabilization step was omitted. Bar, 10 mM.The Journal of Cell Biology, Volume 142, 1998 260
tant to note that these two mechanisms for regulating the
interaction between ankyrin and L1 molecules are not mu-
tually exclusive, and the phosphorylation of the conserved
tyrosine residue in the FIGQY motif might provide an ad-
ditional way to inhibit L1-mediated cell adhesion and L1
binding to the membrane skeleton.
Other types of protein phosphorylation might also be in-
volved in regulating the association of ankyrin with neuro-
glian in vivo or in S2 cells. Several cytoplasmic serine resi-
dues are also highly conserved throughout the L1 family
and some have been shown to be the target of protein ki-
nases (Wong et al., 1996a,b). The phosphorylation of these
residues might have an effect on ankyrin binding to L1
family members and play an important role in the regula-
tion of this interaction in S2 cells.
The regulation of ankyrin binding to L1-type molecules
might also involve the adhesion-induced clustering of sev-
eral L1 molecules within the plane of the plasma mem-
brane, similar to the mechanism of growth factor receptor
activation (Schlessinger and Ullrich, 1992). Alternatively,
the homophilic adhesion process could induce an allosteric
change in the neuroglian molecule. However, the finding
that a chimeric molecule, composed of the extracellular do-
main of a distantly related adhesion molecule coupled to
the cytoplasmic and transmembrane domains of neuroglian,
exhibits the same regulated association with ankyrin as
wild-type neuroglian argues against the allosteric model.
Our results indicate that the tyrosine residue in the con-
served FIGQY motif plays an important role in L1’s inter-
action with the membrane skeleton and its adhesive func-
tion. One of the identified L1-CAM mutations, which
causes a range of neurological phenotypes in humans, re-
sults in the exchange of tyrosine 1229 in the human L1
protein for a histidine residue (Van Camp et al., 1996).
Residue Y1229 in human L1-CAM is homologous to
Y1234 in the Drosophila neuroglian sequence. Consider-
ing that the cytoplasmic domain of human L1 CAM is dis-
pensable for its adhesive function (Wong et al., 1995a), it
has been an enigma why mutations in the cytoplasmic do-
main of human L1-CAM can cause the same range of phe-
notypes as mutations in the extracellular domain. It now
appears that extracellular adhesive and intracellular cy-
toskeletal interactions of L1 molecules are functionally
connected and therefore influence each other. Members of
the L1 family are expressed on advancing growth cones
during development and during regeneration after nerve
injury and by other motile neuronal cells, such as migrat-
ing granule cells (Lindner et al., 1983; Kamiguchi and
Lemmon, 1997). A precise regulation of neuronal adhe-
siveness must be very important in these cells to allow dy-
namic interactions with their cellular environment. Any
mutation interrupting this delicate adhesive balance might
therefore cause the observed wide range of L1 mutant
phenotypes (Wong et al., 1995b; Dahme et al., 1997; Hall
and Bieber, 1997).
We would like to thank C. Goodman (University of California, Berkeley,
CA) for making the fasciclin II cDNA and the anti-fasciclin II antibodies
available to us, C. Palfrey for providing the anti-phosphotyrosine anti-
body, and M. Wert (both from University of Chicago, Chicago, IL) for
PC12 cell samples. We would also like to thank M. Wyche (Alabama A & M
University, Normal, AL) and M. Hadeed for help with several of the de-
scribed experiments and S. Brown and S. Ernst (all three from University
of Michigan, Ann Arbor, MI) for a critical reading of the manuscript. 
The work described in this publication has been supported by grants
from the National Institutes of Health to R.R. Dubreuil (GM 49301 and
DK 42086) and to M. Hortsch (HD 29388).
Received for publication 17 February 1998 and in revised form 2 June
1998.
References
Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A.
Smith, and K. Struhl. 1988. Current Protocols in Molecular Biology. J. Wiley
& Sons, Inc., New York.
Bartel, P.L., C.-t. Chien, R. Sternglanz, and S. Fields. 1993. Using the two-
hybrid system to detect protein-protein interactions. In Cellular Interactions
in Development: A Practical Approach. D.A. Hartley, editor. IRL Press,
Oxford, UK. 153–179.
Bieber, A.J. 1994. Analysis of cellular adhesion in cultured cells. In Drosophila
melanogaster: Practical Uses in Cell Biology. L. Goldstein and E. Fyrberg,
editors. 44:683–696. Academic Press, San Diego, CA.
Bieber, A.J., P.M. Snow, M. Hortsch, N.H. Patel, J.R. Jacobs, Z.R. Traquina, J.
Schilling and C.S. Goodman. 1989. Drosophila neuroglian: a member of the
immunoglobulin superfamily with extensive homology to the vertebrate
neural adhesion molecule L1. Cell. 59:447–460.
Boulton, T.G., S.H. Nye, D.J. Robbins, N.Y. Ip, E. Radziejewska, S.D. Morgen-
besser, R.A. DePinho, N. Panayotatos, M.H. Cobb, and G.D. Yancopoulos.
1991. ERKs: a family of protein-serine/threonine kinases that are activated
and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:663–675.
Clark, E.A., and J.S. Brugge. 1995. Integrins and signal transduction pathways:
the road taken. Science. 268:233–239.
Dahme, M., U. Bartsch, R. Martini, B. Anliker, M. Schachner, and N. Mantei.
1997. Disruption of the mouse L1 gene leads to malformations of the ner-
vous system. Nat. Genet. 17:346–349.
Davis, J.Q., and V. Bennett. 1994. Ankyrin binding activity shared by the neu-
rofascin/L1/NrCAM family of nervous system cell adhesion molecules. J.
Biol. Chem. 269:27163–27166.
Davis, J.Q., T. McLaughlin, and V. Bennett. 1993. Ankyrin-binding proteins re-
lated to nervous system cell adhesion molecules: candidates to provide trans-
membrane and intercellular connections in adult brain. J. Cell Biol. 121:121–133.
Dubreuil, R.R., and J.-Q. Yu. 1994. Ankyrin and beta-spectrin accumulate in-
dependently of alpha-spectrin in Drosophila. Proc. Natl. Acad. Sci. USA. 91:
10285–10289.
Dubreuil, R.R., T.J. Byers, D. Branton, L.S.B. Goldstein, and D.P. Kiehart.
1987. Drosophilia spectrin. I. Characterization of the purified protein. J. Cell
Biol. 105:2095–2102.
Dubreuil, R.R., G. MacVicar, S. Dissanayake, C. Liu, D. Homer, and M.
Hortsch. 1996. Neuroglian-mediated cell adhesion induces assembly of the
membrane skeleton at cell contact sites. J. Cell Biol. 133:647–655.
Dubreuil, R.R., P.B. Maddux, T.A. Grushko, and G.R. MacVicar. 1997. Segre-
gation of two spectrin isoforms: polarized membrane-binding sites direct po-
larized membrane skeleton assembly. Mol. Biol. Cell. 8:1933–1942.
Durfee, T., K. Becherer, P.L. Chen, S.H. Yeh, Y. Yang, A.E. Kilburn, W.H.
Lee, and S.J. Elledge. 1993. The retinoblastoma protein associates with the
protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555–569.
Garver, T.D., Q. Ren, S. Tuvia, and V. Bennett. 1997. Tyrosine phosphoryla-
tion at a site highly conserved in the L1 family of cell adhesion molecules
abolishes ankyrin binding and increases lateral mobility of neurofascin. J.
Cell Biol. 137:703–714.
Grenningloh, G., E.J. Rehm, and C.S. Goodman. 1991. Genetic analysis of
growth cone guidance in Drosophila: fasciclin II functions as a neuronal rec-
ognition molecule. Cell. 67:45–57.
Gumbiner, B.M. 1995. Signal transduction of beta-catenin. Curr. Opin. Cell
Biol. 7:634–640.
Hall, S.G., and A.J. Bieber. 1997. Mutations in the Drosophila neuroglian cell
adhesion molecule affect motor neuron pathfinding and peripheral nervous
system patterning. J. Neurobiol. 32:325–340.
Hortsch, M. 1996. The L1 family of neural cell adhesion molecules: old proteins
performing new tricks. Neuron. 17:587–593.
Hortsch, M., D. Avossa, and D.I. Meyer. 1985. A structural and functional anal-
ysis of the docking protein. Characterization of active domains by proteoly-
sis and specific antibodies. J. Biol. Chem. 260:9137–9145.
Hortsch, M., K.S. O’Shea, G. Zhao, F. Kim, Y. Vallejo, and R.R. Dubreuil.
1998. A conserved role for L1 as a transmembrane link between neuronal
adhesion and membrane cytoskeleton assembly. Cell Adh. Comm. 5:61–73.
Hortsch, M., Y.M. Wang, Y. Marikar, and A.J. Bieber. 1995. The cytoplasmic do-
main of the Drosophila cell adhesion molecule neuroglian is not essential for
its homophilic adhesive properties in S2 cells. J. Biol. Chem. 270:18809–18817.
Kamiguchi, H., and V. Lemmon. 1997. Neural cell adhesion molecule L1: sig-
naling pathways and growth cone motility. J. Neurosci. Res. 49:1–8.
Lindner, J., F.G. Rathjen, and M. Schachner. 1983. L1 mono- and polyclonal
antibodies modify cell migration in early postnatal mouse cerebellum. Na-
ture. 305:427–430.
Nelson, W.J., and P.J. Veshnock. 1987. Ankyrin binding to (Na1, K1)ATPaseHortsch et al. Requirements for Neuroglian Signaling 261
and implications for the organization of membrane domains in polarized
cells. Nature. 328:533–536.
Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-
terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463–5467.
Schlessinger, J., and A. Ullrich. 1992. Growth factor signaling by receptor ty-
rosine kinases. Neuron. 9:383–391.
She, H.-y., S. Rockow, J. Tang, R. Nishimura, E.Y. Skolnik, M. Chen, B. Mar-
golis, and W. Li. 1997. Wiskott-Aldrich Syndrome protein is associated with
the adapter protein Grb2 and the epidermal growth factor receptor in living
cells. Mol. Biol. Cell. 8:1709–1721.
Tuvia, S., T.D. Garver, and V. Bennett. 1997. The phosphorylation state of the
FIGQY tyrosine of neurofascin determines ankyrin-binding activity and pat-
terns of cell segregation. Proc. Natl. Acad. Sci. USA. 94:12957–12962.
Vallejo, Y., M. Hortsch, and R.R. Dubreuil. 1997. Ethanol does not inhibit the
adhesive activity of Drosophila neuroglian or human L1 in Drosophila S2
tissue culture cells. J. Biol. Chem. 272: 12244–12247.
Van Camp, G., E. Fransen, L. Vits, G. Raes, and P.J. Willems. 1996. A locus-
specific mutation database for the neural cell adhesion molecule L1CAM
(Xq28). Hum. Mutat. 8:391.
Walsh, F.S., and P. Doherty. 1997. Neural cell adhesion molecules of the immu-
noglobulin superfamily: Role in axon growth and guidance. Annu. Rev. Cell
Dev. Biol. 13:425–456.
Wong, E.V., G.H. Cheng, H.R. Payne, and V. Lemmon. 1995a. The cytoplasmic
domain of the cell-adhesion molecule L1 is not required for homophilic ad-
hesion. Neurosci. Lett. 200:155–158.
Wong, E.V., S. Kenwrick, P. Willems, and V. Lemmon. 1995b. Mutations in the
cell adhesion molecule L1 cause mental retardation. Trends Neurosci. 18:
168–172.
Wong, E.V., A.W. Schaefer, G. Landreth, and V. Lemmon. 1996a. Casein ki-
nase-II phosphorylates the neural cell-adhesion molecule L1. J. Neurochem.
66:779–786.
Wong, E.V., A.W. Schaefer, G. Landreth, and V. Lemmon. 1996b. Involvement
of p90rsk in neurite outgrowth mediated by the cell adhesion molecule L1. J.
Biol. Chem. 271:18217–18223.